Updated Guidelines for Managing Aromatase Inhibitor-Induced Bone Loss in Hormone-Sensitive Breast Cancer Patients
A groundbreaking joint position statement was recently published, offering an updated roadmap for managing aromatase inhibitor-associated bone loss (AIBL) in ...
